Ekso Bionics (NASDAQ:EKSO) Posts Quarterly Earnings Results, Misses Estimates By $0.02 EPS

Ekso Bionics (NASDAQ:EKSO) issued its quarterly earnings results on Monday. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.02), Yahoo Finance reports. Ekso Bionics had a negative return on equity of 92.08% and a negative net margin of 68.41%. The firm had revenue of $4.13 million during the quarter, compared to analyst estimates of $6.00 million. During the same period in the prior year, the firm earned ($0.24) earnings per share.

Ekso Bionics Price Performance

NASDAQ:EKSO opened at $0.90 on Tuesday. The stock has a 50 day moving average price of $1.11 and a 200 day moving average price of $1.15. The stock has a market cap of $16.36 million, a PE ratio of -1.16 and a beta of 1.45. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.77 and a current ratio of 2.42. Ekso Bionics has a one year low of $0.83 and a one year high of $3.13.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on EKSO. StockNews.com began coverage on Ekso Bionics in a report on Saturday. They issued a “hold” rating on the stock. HC Wainwright decreased their price target on shares of Ekso Bionics from $10.00 to $9.00 and set a “buy” rating on the stock in a research note on Tuesday.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.